meloxicam

Also known as Mobic®, UHAC-62XX, UNII-VG2QF83CGL, UNII-vg2qf83cgl, Méloxicam, Meloxicamum

Key facts

Drug.Verifiedfields: changed
Drug.Watchedfields: changed
Drug.verifiedrevid: 459437267
Drug.image: Meloxicam2DACS.svg
Drug.image_class: skin-invert-image
Drug.width: 200
Drug.image2: Meloxicam-from-xtal-3D-bs-17.png
Drug.image_class2: bg-transparent
Drug.tradename: Mobic, Meloxidyl, others
Drug.MedlinePlus: a601242
Drug.DailyMedID: Meloxicam
Drug.pregnancy_AU: C
Drug.routes_of_administration

~13 min read

Article

23 sections

Contents

Medical uses
Adverse effects
Cardiovascular
Gastrointestinal
Mechanism of action
Pharmacokinetics
Absorption
Distribution
Metabolism
Excretion
Research and development
Veterinary use
Use of meloxicam in cats
US policy vs EU policy
Dosage and safety margin
Additional studies
Pharmacokinetics
Legal status
United States
European Union
Other countries
See also
References

Meloxicam, sold under the brand name Mobic among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation in rheumatic diseases and osteoarthritis. It is taken by mouth or given by injection into a vein. It is recommended that it be used for as short a period as possible and at a low dose.

Common side effects include abdominal pain, dizziness, swelling, headache, and a rash. Serious side effects may include heart disease, stroke, kidney problems, and stomach ulcers. Use is not recommended in the third trimester of pregnancy. It blocks cyclooxygenase-2 (COX-2) more than it blocks cyclooxygenase-1 (COX-1). It is in the oxicam family of chemicals and is closely related to piroxicam.